D. E. Shaw & Co., Inc. BRIDGEBIO PHARMA INC Transaction History

D. E. Shaw & Co., Inc.

  • $156 Billion
  • Q3 2025
Number of Shares
28,652,000
Previous 22,061,000 29.88%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
N/A
6,591,000 Added 29.88%
28,652,000 $0
Q2 2025

Aug 14, 2025
BUY
N/A
7,311,000 Added 49.57%
22,061,000 $0
Q1 2025

May 15, 2025
SELL
N/A
-37,000,000 Reduced 71.5%
14,750,000 $0
Q4 2024

Feb 14, 2025
SELL
N/A
-500,000 Reduced 0.96%
51,750,000 $0
Q3 2023

Nov 14, 2023
SELL
N/A
-2,100,000 Reduced 3.86%
52,250,000 $0
Q2 2023

Aug 14, 2023
BUY
N/A
24,600,000 Added 82.69%
54,350,000 $0
Q1 2023

May 15, 2023
BUY
N/A
29,750,000 New
29,750,000 $0
Q2 2022

Aug 15, 2022
SELL
N/A
-2,473,000 Closed
0 $0
Q1 2022

May 16, 2022
BUY
N/A
2,473,000 New
2,473,000 $1.19 Million
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email